Nanotechnology has expanded into a broad range of clinical applications. In particular,
metal nanoparticles (MNPs) display unique antimicrobial properties, a fundamental function …

The acronym ESKAPE includes six nosocomial pathogens that exhibit multidrug resistance
and virulence: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae …

Resistance to antimicrobial agents has been alarming in recent years and poses a huge
public health threat globally according to the WHO. The increase in morbidity and mortality …

Nanotechnology using nanoscale materials is increasingly being utilized for clinical
applications, especially as a new paradigm for infectious diseases. Infections caused by …

Infectious diseases remain one of the leading causes of morbidity and mortality worldwide.
The WHO and CDC have expressed serious concern regarding the continued increase in …

The inappropriate use of antibiotics and an inadequate control of infections have led to the
emergence of resistant strains which represent a major threat to public health and the global …

Silver nanoparticles have already been successfully applied in various biomedical and
antimicrobial technologies and products used in everyday life. Although bacterial resistance …

Nanomaterials represent a promising novel class of materials to be used as antibacterial
solutions. Inhomogeneity of synthesis and characterization methods, as well as resulting …

Despite an array of cogent antibiotics, bacterial infections, notably those produced by
nosocomial pathogens, still remain a leading factor of morbidity and mortality around the …

The ability of microorganisms to generate resistance outcompetes with the generation of
new and efficient antibiotics; therefore, it is critical to develop novel antibiotic agents and …